UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Prof David Taylor
Appointment
  • Emeritus Professor Of Pharmaceutical and Public Health Policy
  • Practice & Policy
  • UCL School of Pharmacy
  • Faculty of Life Sciences
Role
UCL Principal Supervisor,UCL Subsidiary Supervisor
Biography

David Taylor has had a personal chair as Professor of Pharmaceutical and Public Health Policy at The School since 2001.  In the 1970s he was deputy director of the Office of Health Economics, where he undertook early work on topics such as GP fund holding and improving poor world medicines supply. He subsequently became a director the Association of the British Pharmaceutical Industry, a King’s Fund Fellow and an associate director of the Audit Commission for England and Wales. At the latter he had national responsibilities for work on health care quality and wrote the Commission’s report Dear to our Hearts? This preceded the NSF on Coronary Heart Disease. 

In the NHS he served as a chairman of a Family Practitioner Committee and a Family Health Services Authority in the 1980s and 1990s. Between 2001 and 2009 was chairman of a Mental Health Trust, which gained Foundation status in 2008. He subsequently joined the Camden PCT Board.

David was awarded the Royal Pharmaceutical Society’s Synergy Prize for the non-pharmacist who contributed most to pharmacy in 2008, and made a life member of the Society in 2010. He is a member of the Faculty of Public Health and has recently (2010/11) been a member of the DH Public Health Leadership Forum for Pharmacy and the Royal College of Physicians Medicines Forum Patients’ Perspective working group. Internationally, he is currently a member of the FIP Centennial Roundtable Committee and has ongoing working links with members of various other European and US organisations, including the Pharmaceutical Research and Manufacturers of America and the UCSF School of Pharmacy.

Research Groups
Research Themes
Research Summary

David Taylor’s research interests centre on the development, supply and effective use of pharmaceutical products to promote enhanced welfare in Europe and globally. He is in particular focused on policy issues relating to the productivity and future social and economic sustainability of the research based pharmaceutical industry, and on the future development, productivity and sustainability of primary health care systems and, within the latter, community pharmacy. 

With Professor Michael Bury he has developed a theoretical model called care transition. This locates medical, pharmaceutical and wider national and global health improvement issues – including the evolving nature of professionalism and changing public and political expectations relating to the quality of medicines and health care provision – within an overall social and economic framework. It draws on the work of sociologists such as Elliot Freidson and John McKinley, psychologists such as James Flynn, development and health sector theorists like Ronald Inglehart and Brian Salter, and quality management writers such as W. Edwards Deming.

As of June 2011 David’s portfolio of ongoing projects includes work with Professor David Colin-Thomé on primary care, Professor Sir Nicholas Wald on issues relating to vascular disease prevention and the use of medicines to achieve public health improvement goals, Dr Tina Brock (Associate Dean of Teaching and Learning at UCSF School of Pharmacy) on the global development of community pharmacy services and Dr Panos Kanavos of LSE Health. Professor Taylor and Dr Kanavos are working together on a range of pharmaceutical sector topics relevant to the EU, US and other market contexts. David’s main corporate partners include Alliance Boots and Pfizer. Pfizer has funded The School’s annual Royal Society lecture since its inception by David in 2008.

Areas of Expertise
(Public) health policy analysis, pharmaceutical Industry policy and development, health economics, medical sociology, primary care development (including general practice, community nursing and community pharmacy), mental health care policy and services, medicines/health service user support, health care quality management, political and public communications. 

Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by